\-\ Texto\\:\\ \ \(0\)\
\-\ unknown\ \(157\)\
\-\ type\\ ii\\ endoleaks\\ are\\ a\\ result\\ of\\ flow\\ from\\ small\\ arteries\\ such\\ as\\ the\\ lumbars\\ or\\ the\\ inferior\\ mesenteric\\ artery\\ \\(ima\\)\\.\\ detection\\ of\\ a\\ type\\ ii\\ endoleak\\ can\\ be\\ accomplished\\ by\\ routine\\ duplex\\ ultrasound\\,\\ but\\ is\\ more\\ commonly\\ performed\\ by\\ ct\\ scanning\\.\\ both\\ methods\\ have\\ some\\ disadvantages\\;\\ however\\,\\ the\\ most\\ serious\\ problem\\ is\\ related\\ to\\ ct\\ scanning\\.\\ the\\ timing\\ of\\ contrast\\ injection\\ during\\ the\\ ct\\ scan\\ will\\ determine\\ whether\\ a\\ type\\ ii\\ endoleak\\ is\\ visible\\.\\ due\\ to\\ the\\ nature\\ of\\ retrograde\\ flow\\,\\ these\\ can\\ be\\ very\\ low\\-flow\\ systems\\.\\ delayed\\ films\\ may\\ be\\ necessary\\ to\\ assess\\ late\\ perfusion\\ within\\ the\\ sac\\ and\\ should\\ be\\ performed\\ with\\ any\\ suspicion\\ of\\ type\\ ii\\ endoleak\\.\ \(0\)\
\-\ axial\\ computed\\ tomography\\ images\\ demonstrate\\ 2\\ collateral\\ vessels\\ in\\ the\\ aneurysm\\ sac\\ on\\ each\\ side\\.\\ this\\ is\\ consistent\\ with\\ retrograde\\ filling\\ by\\ these\\ vessels\\ and\\ constitutes\\ the\\ presence\\ of\\ a\\ type\\ 2\\ endograft\\ leak\\.\ \(0\)\
\-\ endograft\\ leak\\ \\-\\ type\\ ii\\ involving\\ the\\ l3\\ lumbar\\ artery\\ and\\ inferior\\ mesenteric\\ artery\\.\ \(0\)\
\-\ none\\.\\ this\\ finding\\ is\\ very\\ specific\\ for\\ a\\ type\\ ii\\ endograft\\ leak\\.\ \(0\)\
\-\ 59\\ year\\ old\\ black\\ male\\ with\\ long\\-standing\\ history\\ of\\ hypertension\\,\\ hyperlipidemia\\,\\ and\\ type\\ ii\\ diabetes\\ who\\ was\\ found\\ to\\ have\\ an\\ infrarenal\\ abdominal\\ aortic\\ aneurysm\\.\\ the\\ patient\\ underwent\\ an\\ endograft\\ repair\\ 10\\ days\\ prior\\ to\\ ct\\ scan\\.\\ the\\ ct\\ scan\\ was\\ ordered\\ for\\ routine\\ post\\-operative\\ evaluation\\.\ \(0\)\
\-\ interventionalists\\ debate\\ the\\ significance\\ of\\ type\\ ii\\ endoleaks\\,\\ as\\ many\\ of\\ these\\ leaks\\ will\\ spontaneously\\ resolve\\,\\ regardless\\ of\\ graft\\ type\\.\\ \ \(0\)\
\-\ some\\ patients\\ will\\ demonstrate\\ stability\\ or\\ even\\ shrinkage\\ of\\ the\\ aneurysm\\ sac\\ in\\ the\\ presence\\ of\\ a\\ patent\\ type\\ ii\\ endoleak\\;\\ usually\\ they\\ can\\ be\\ safely\\ observed\\ for\\ 6\\ months\\.\\ \ \(0\)\
\-\ an\\ aggressive\\ approach\\ to\\ treating\\ all\\ persistent\\ endoleaks\\ at\\ 6\\ months\\ is\\ usually\\ adopted\\ and\\ consideration\\ of\\ further\\ conservative\\ treatment\\ only\\ when\\ a\\ type\\ ii\\ endoleak\\ is\\ difficult\\ to\\ treat\\ and\\ the\\ aneurysm\\ sac\\ is\\ shrinking\\ in\\ size\\.\\ \ \(0\)\
\-\ it\\ should\\ be\\ noted\\ that\\ most\\ type\\ ii\\ endoleaks\\ have\\ a\\ benign\\ course\\ and\\ aggressive\\ treatment\\ should\\ not\\ involve\\ excessive\\ patient\\ morbidity\\.\\ \ \(0\)\
\-\ in\\ this\\ setting\\,\\ successful\\ embolization\\ performed\\ via\\ transarterial\\ or\\ translumbar\\ techniques\\ can\\ be\\ peroformed\\ by\\ a\\ skilled\\ interventionalist\\ as\\ clinically\\ required\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ii\\:\\ 0\\.10668899157757282\ \(0\)\
\-\ type\\:\\ 0\\.09854767096976273\ \(0\)\
\-\ endoleak\\:\\ 0\\.0948168488359526\ \(0\)\
\-\ endoleaks\\:\\ 0\\.0854986446674374\ \(0\)\
\-\ endograft\\:\\ 0\\.07090607244512276\ \(0\)\
\-\ sac\\:\\ 0\\.043607258836890435\ \(0\)\
\-\ leak\\:\\ 0\\.040473465551467594\ \(0\)\
\-\ aneurysm\\:\\ 0\\.03555199068466634\ \(0\)\
\-\ scanning\\:\\ 0\\.027536839397423095\ \(0\)\
\-\ retrograde\\:\\ 0\\.02698231036764506\ \(0\)\
\-\ be\\:\\ 0\\.024274465956335534\ \(0\)\
\-\ lumbars\\:\\ 0\\.02319873269464868\ \(0\)\
\-\ interventionalists\\:\\ 0\\.02319873269464868\ \(0\)\
\-\ transarterial\\:\\ 0\\.02319873269464868\ \(0\)\
\-\ translumbar\\:\\ 0\\.02319873269464868\ \(0\)\
\-\ peroformed\\:\\ 0\\.02319873269464868\ \(0\)\
\-\ interventionalist\\:\\ 0\\.02319873269464868\ \(0\)\
\-\ aggressive\\:\\ 0\\.022004154924930856\ \(0\)\
\-\ should\\:\\ 0\\.02150690954122737\ \(0\)\
\-\ low\\-flow\\:\\ 0\\.02137466116685935\ \(0\)\
\-\ will\\:\\ 0\\.021106429092466912\ \(0\)\
\-\ mesenteric\\:\\ 0\\.0207385321092913\ \(0\)\
\-\ can\\:\\ 0\\.020402340552305994\ \(0\)\
\-\ disadvantages\\:\\ 0\\.02030764772446944\ \(0\)\
\-\ constitutes\\:\\ 0\\.02030764772446944\ \(0\)\
\-\ shrinkage\\:\\ 0\\.02030764772446944\ \(0\)\
\-\ skilled\\:\\ 0\\.02030764772446944\ \(0\)\
\-\ artery\\:\\ 0\\.020088394674538414\ \(0\)\
\-\ adopted\\:\\ 0\\.01955058963907002\ \(0\)\
\-\ shrinking\\:\\ 0\\.01955058963907002\ \(0\)\
\-\ scan\\:\\ 0\\.0188863536349972\ \(0\)\
\-\ performed\\:\\ 0\\.01880982893074199\ \(0\)\
\-\ vessels\\:\\ 0\\.018106526401485964\ \(0\)\
\-\ routine\\:\\ 0\\.01803392996921051\ \(0\)\
\-\ ima\\:\\ 0\\.01772651811128069\ \(0\)\
\-\ safely\\:\\ 0\\.01772651811128069\ \(0\)\
\-\ these\\:\\ 0\\.01755666862071979\ \(0\)\
\-\ debate\\:\\ 0\\.017416562754290207\ \(0\)\
\-\ leaks\\:\\ 0\\.017416562754290207\ \(0\)\
\-\ timing\\:\\ 0\\.01644886596448674\ \(0\)\
\-\ very\\:\\ 0\\.016325187465563835\ \(0\)\
\-\ presence\\:\\ 0\\.016325187465563835\ \(0\)\
\-\ infrarenal\\:\\ 0\\.01590244658349136\ \(0\)\
\-\ regardless\\:\\ 0\\.015742908105027056\ \(0\)\
\-\ ct\\:\\ 0\\.015727679649895302\ \(0\)\
\-\ long\\-standing\\:\\ 0\\.015592491226500879\ \(0\)\
\-\ methods\\:\\ 0\\.01545020906526331\ \(0\)\
\-\ inferior\\:\\ 0\\.015259559796626647\ \(0\)\
\-\ by\\:\\ 0\\.014977588455209207\ \(0\)\
\-\ duplex\\:\\ 0\\.014947432126414075\ \(0\)\
\-\ flow\\:\\ 0\\.014863441457150085\ \(0\)\
\-\ have\\:\\ 0\\.014608721671303357\ \(0\)\
\-\ serious\\:\\ 0\\.01442977345734551\ \(0\)\
\-\ significance\\:\\ 0\\.014337427878894799\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.013918836577237729\ \(0\)\
\-\ treating\\:\\ 0\\.013918836577237729\ \(0\)\
\-\ morbidity\\:\\ 0\\.013696317135058615\ \(0\)\
\-\ some\\:\\ 0\\.013657517125614521\ \(0\)\
\-\ usually\\:\\ 0\\.013657517125614521\ \(0\)\
\-\ excessive\\:\\ 0\\.01362613753747398\ \(0\)\
\-\ accomplished\\:\\ 0\\.01349115518382253\ \(0\)\
\-\ l3\\:\\ 0\\.01349115518382253\ \(0\)\
\-\ 6\\:\\ 0\\.013432211375657232\ \(0\)\
\-\ techniques\\:\\ 0\\.013426174624374185\ \(0\)\
\-\ resolve\\:\\ 0\\.01330083765334983\ \(0\)\
\-\ graft\\:\\ 0\\.01330083765334983\ \(0\)\
\-\ detection\\:\\ 0\\.013066765321727474\ \(0\)\
\-\ post\\-operative\\:\\ 0\\.013011361613312126\ \(0\)\
\-\ black\\:\\ 0\\.01295710033119966\ \(0\)\
\-\ perfusion\\:\\ 0\\.01280072290890808\ \(0\)\
\-\ spontaneously\\:\\ 0\\.012701406256321641\ \(0\)\
\-\ treat\\:\\ 0\\.012701406256321641\ \(0\)\
\-\ stability\\:\\ 0\\.012559124095084074\ \(0\)\
\-\ consideration\\:\\ 0\\.012559124095084074\ \(0\)\
\-\ problem\\:\\ 0\\.0122957465725657\ \(0\)\
\-\ months\\:\\ 0\\.012283901551000355\ \(0\)\
\-\ whether\\:\\ 0\\.012094765049448399\ \(0\)\
\-\ 59\\:\\ 0\\.012094765049448399\ \(0\)\
\-\ tomography\\:\\ 0\\.012018482057676682\ \(0\)\
\-\ successful\\:\\ 0\\.011981154070855744\ \(0\)\
\-\ systems\\:\\ 0\\.011944348170922218\ \(0\)\
\-\ computed\\:\\ 0\\.011872245607269283\ \(0\)\
\-\ is\\:\\ 0\\.011837700597573171\ \(0\)\
\-\ approach\\:\\ 0\\.01180206600968465\ \(0\)\
\-\ collateral\\:\\ 0\\.011767665795033721\ \(0\)\
\-\ late\\:\\ 0\\.011700185714472308\ \(0\)\
\-\ suspicion\\:\\ 0\\.0116670836560332\ \(0\)\
\-\ each\\:\\ 0\\.011634392813931735\ \(0\)\
\-\ determine\\:\\ 0\\.011386531721669365\ \(0\)\
\-\ setting\\:\\ 0\\.011357128299042719\ \(0\)\
\-\ assess\\:\\ 0\\.011270839291613795\ \(0\)\
\-\ diabetes\\:\\ 0\\.011133028803410331\ \(0\)\
\-\ patent\\:\\ 0\\.0110798637841537\ \(0\)\
\-\ observed\\:\\ 0\\.010781630401766851\ \(0\)\
\-\ \\;\\:\\ 0\\.010660111518171545\ \(0\)\
\-\ visible\\:\\ 0\\.010644299472370614\ \(0\)\
\-\ nature\\:\\ 0\\.010644299472370614\ \(0\)\
\-\ involve\\:\\ 0\\.010600070213643295\ \(0\)\
\-\ ordered\\:\\ 0\\.010578231258867782\ \(0\)\
\-\ injection\\:\\ 0\\.010492643912274204\ \(0\)\
\-\ embolization\\:\\ 0\\.01047167504477637\ \(0\)\
\-\ most\\:\\ 0\\.0103833428512004\ \(0\)\
\-\ demonstrate\\:\\ 0\\.01034974811227916\ \(0\)\
\-\ as\\:\\ 0\\.010204559257058904\ \(0\)\
\-\ even\\:\\ 0\\.010012850341763796\ \(0\)\
\-\ necessary\\:\\ 0\\.009960738164668586\ \(0\)\
\-\ clinically\\:\\ 0\\.009859511109858596\ \(0\)\
\-\ difficult\\:\\ 0\\.009843012128243872\ \(0\)\
\-\ 2\\:\\ 0\\.009684760507950243\ \(0\)\
\-\ via\\:\\ 0\\.009652694597771171\ \(0\)\
\-\ lumbar\\:\\ 0\\.009562460193880035\ \(0\)\
\-\ a\\:\\ 0\\.009393153200966873\ \(0\)\
\-\ an\\:\\ 0\\.009328933139089973\ \(0\)\
\-\ arteries\\:\\ 0\\.009308957275621003\ \(0\)\
\-\ specific\\:\\ 0\\.009295564987443447\ \(0\)\
\-\ related\\:\\ 0\\.009282240508610429\ \(0\)\
\-\ films\\:\\ 0\\.009282240508610429\ \(0\)\
\-\ many\\:\\ 0\\.009242667147124796\ \(0\)\
\-\ delayed\\:\\ 0\\.00915257985332942\ \(0\)\
\-\ treatment\\:\\ 0\\.009103247155794142\ \(0\)\
\-\ aortic\\:\\ 0\\.009102453024459172\ \(0\)\
\-\ filling\\:\\ 0\\.009053263200742982\ \(0\)\
\-\ repair\\:\\ 0\\.009004975993721413\ \(0\)\
\-\ conservative\\:\\ 0\\.00898116063709005\ \(0\)\
\-\ persistent\\:\\ 0\\.00896933329606942\ \(0\)\
\-\ hypertension\\:\\ 0\\.00886521329552681\ \(0\)\
\-\ unknown\\:\\ 0\\.008775998685853964\ \(0\)\
\-\ result\\:\\ 0\\.008626800413020951\ \(0\)\
\-\ commonly\\:\\ 0\\.008485609061725371\ \(0\)\
\-\ course\\:\\ 0\\.008485609061725371\ \(0\)\
\-\ they\\:\\ 0\\.008102489806545543\ \(0\)\
\-\ required\\:\\ 0\\.008094014504703326\ \(0\)\
\-\ or\\:\\ 0\\.007906758544450323\ \(0\)\
\-\ involving\\:\\ 0\\.007890545431587615\ \(0\)\
\-\ to\\:\\ 0\\.007867044102897115\ \(0\)\
\-\ side\\:\\ 0\\.0077906486888528175\ \(0\)\
\-\ benign\\:\\ 0\\.007760658860613687\ \(0\)\
\-\ underwent\\:\\ 0\\.00771630535652163\ \(0\)\
\-\ this\\:\\ 0\\.007587925368269472\ \(0\)\
\-\ 10\\:\\ 0\\.007580590074597132\ \(0\)\
\-\ size\\:\\ 0\\.007539147029944135\ \(0\)\
\-\ finding\\:\\ 0\\.007247530276417056\ \(0\)\
\-\ further\\:\\ 0\\.007151168794211206\ \(0\)\
\-\ found\\:\\ 0\\.007086909511716085\ \(0\)\
\-\ any\\:\\ 0\\.007081144823874457\ \(0\)\
\-\ such\\:\\ 0\\.007029823131160138\ \(0\)\
\-\ days\\:\\ 0\\.006892300779399941\ \(0\)\
\-\ during\\:\\ 0\\.006881603289273179\ \(0\)\
\-\ only\\:\\ 0\\.006761609627591936\ \(0\)\
\-\ ultrasound\\:\\ 0\\.006671375223700798\ \(0\)\
\-\ evaluation\\:\\ 0\\.006532207357438967\ \(0\)\
\-\ when\\:\\ 0\\.006440345362147383\ \(0\)\
\-\ axial\\:\\ 0\\.006417872305441767\ \(0\)\
\-\ all\\:\\ 0\\.006360324972187607\ \(0\)\
\-\ however\\:\\ 0\\.006261494883150185\ \(0\)\
\-\ due\\:\\ 0\\.006000729349875894\ \(0\)\
\-\ who\\:\\ 0\\.005863074760899215\ \(0\)\
\-\ the\\:\\ 0\\.005821022513836875\ \(0\)\
\-\ patients\\:\\ 0\\.005819933156226384\ \(0\)\
\-\ prior\\:\\ 0\\.005773980979479904\ \(0\)\
\-\ for\\:\\ 0\\.005756116962968804\ \(0\)\
\-\ both\\:\\ 0\\.005742631554437162\ \(0\)\
\-\ \\,\\:\\ 0\\.005699159274048155\ \(0\)\
\-\ more\\:\\ 0\\.0056241481824004375\ \(0\)\
\-\ abdominal\\:\\ 0\\.005620840100321356\ \(0\)\
\-\ none\\:\\ 0\\.00557820922870528\ \(0\)\
\-\ consistent\\:\\ 0\\.005513942812713692\ \(0\)\
\-\ noted\\:\\ 0\\.005330055759085773\ \(0\)\
\-\ was\\:\\ 0\\.005201460643229931\ \(0\)\
\-\ small\\:\\ 0\\.005180461274687154\ \(0\)\
\-\ it\\:\\ 0\\.005054864169823728\ \(0\)\
\-\ contrast\\:\\ 0\\.005033620228441856\ \(0\)\
\-\ may\\:\\ 0\\.004932443076047694\ \(0\)\
\-\ \\-\\:\\ 0\\.004820338049232535\ \(0\)\
\-\ but\\:\\ 0\\.004796061318509309\ \(0\)\
\-\ patient\\:\\ 0\\.004508378583770463\ \(0\)\
\-\ in\\:\\ 0\\.004435760317265842\ \(0\)\
\-\ images\\:\\ 0\\.0043138523472351425\ \(0\)\
\-\ within\\:\\ 0\\.004289819495752846\ \(0\)\
\-\ male\\:\\ 0\\.004066330362861772\ \(0\)\
\-\ of\\:\\ 0\\.003985656343089078\ \(0\)\
\-\ that\\:\\ 0\\.0038841598119969036\ \(0\)\
\-\ from\\:\\ 0\\.0033327255609321375\ \(0\)\
\-\ and\\:\\ 0\\.003315955368751392\ \(0\)\
\-\ not\\:\\ 0\\.0032495228203735143\ \(0\)\
\-\ history\\:\\ 0\\.0031058277308081144\ \(0\)\
\-\ are\\:\\ 0\\.0030654575592884256\ \(0\)\
\-\ at\\:\\ 0\\.003046745139030613\ \(0\)\
\-\ year\\:\\ 0\\.0025160664980866175\ \(0\)\
\-\ old\\:\\ 0\\.0023024594654269858\ \(0\)\
\-\ on\\:\\ 0\\.0019049763483300738\ \(0\)\
\-\ \\(\\:\\ 0\\.0019009519111680539\ \(0\)\
\-\ \\)\\:\\ 0\\.0018777307687192239\ \(0\)\
\-\ \\.\\:\\ 0\\.0017749768048673138\ \(0\)\
\-\ with\\:\\ 0\\.0009237171796570243\ \(0\)\
